share_log

B. Riley Securities Reiterates Buy on Altimmune, Maintains $20 Price Target

Moomoo 24/7 ·  Mar 28 11:56

B. Riley Securities analyst Mayank Mamtani reiterates Altimmune (NASDAQ:ALT) with a Buy and maintains $20 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment